← Leaderboards
Russell L Margolis
Johns Hopkins University
$10,931,342
Attributed
$11,606,412
Total exposure
19
Grants
16
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $927.9K · FY2006–24$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$11,606,412 · 19
By mechanism
R21$5,689,993 · 13
R01$4,194,749 · 2
T32$755,025 · 1
P01$498,448 · 1
P50$468,197 · 1
M01$0 · 1
Top collaborators
- Jun Hua2 shared
- Yi Xing2 shared
- Xiping Zhan1 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Jerry L Prince$19,706,671
- Dobrila Doda Rudnicki$1,756,333
- Sarah A Woodson$16,306,396
- Wenzhen Duan$10,264,448
- Sheng Bi$6,395,277
Others in their field
Top investigators on “Pathogenesis”
- Jeffrey P Krischer · University Of South Florida$473,867,135
- Constance Ann Benson · University Of California, San Diego$309,631,408
- Daniel R Kuritzkes · Brigham And Women'S Hospital$212,627,101
- Richard K. Wilson · Washington University$203,917,615
- Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health$198,007,440
- Carol Nesel · Westat$147,274,423
Research focus
PathogenesisHuntington DiseaseBrainGenesBaseCellsNeurodegenerative DisordersLeadTranscriptLengthToxic EffectResearch StudyMutationCag RepeatPropertyCell ModelMouse ModelExonsPathway InteractionsCell LineProteinsMutantProgramsNew Therapeutic Target
Grant awards (45)
Interdisciplinary Training in Psychiatry and Neuroscience$349,509
T32 · FY2024 · MH · contact PI
Interdisciplinary Training in Psychiatry and Neuroscience$405,516
T32 · FY2023 · MH · contact PI
Diffeomorphometry applied to functional connectivity in schizophrenia using ultrahigh resolution MRI$245,027
R21 · FY2023 · MH · contact PI
Diffeomorphometry applied to functional connectivity in schizophrenia using ultrahigh resolution MRI$220,187
R21 · FY2022 · MH · contact PI
Endogenous regulation of huntingtin expression as a therapeutic target for Huntington's disease$470,932
R01 · FY2021 · NS · contact PI
Comparison of HD and HDL2 mouse models to reveal common mechanisms of pathogenesis$450,313
R21 · FY2021 · NS · contact PI
Endogenous regulation of huntingtin expression as a therapeutic target for Huntington's disease$470,932
R01 · FY2020 · NS · contact PI
Junctophilin-3, calcium homeostasis, and neuronal dysfunction in HDL2$457,000
R21 · FY2020 · NS · contact PI
Endogenous regulation of huntingtin expression as a therapeutic target for Huntington's disease$470,932
R01 · FY2019 · NS · contact PI
Endogenous regulation of huntingtin expression as a therapeutic target for Huntington's disease$470,932
R01 · FY2018 · NS · contact PI
Endogenous regulation of huntingtin expression as a therapeutic target for Huntington's disease$470,333
R01 · FY2017 · NS · contact PI
Thalamic connectivity in recent onset schizophrenia measured by 7T fMRI$202,285
R21 · FY2017 · MH · contact PI
Thalamic connectivity in recent onset schizophrenia measured by 7T fMRI$258,196
R21 · FY2016 · MH · contact PI
Spinocerebellar ataxia type 12 iPSCs and PP2A dysregulation$243,000
R21 · FY2016 · NS · contact PI
Spinocerebellar ataxia type 12 iPSCs and PP2A dysregulation$202,500
R21 · FY2015 · NS · contact PI
Small molecule screen to suppress expression of mutant huntington$202,500
R21 · FY2015 · NS · contact PI
Small molecule screen to suppress expression of mutant huntington$243,000
R21 · FY2014 · NS · contact PI
iPS Cells for Investigation of HDL2 and HD Pathogenesis$200,475
R21 · FY2014 · NS · contact PI
iPS Cells for Investigation of HDL2 and HD Pathogenesis$243,000
R21 · FY2013 · NS · contact PI
Transcriptome in Huntington's disease and Huntington's disease-like 2$150,846
R21 · FY2013 · NS
Transcriptome in Huntington's disease and Huntington's disease-like 2$281,814
R21 · FY2012 · NS
Huntington's Disease Antisense Transcript$241,080
R21 · FY2011 · NS · contact PI
Neurons from pluripotent stem cells derived from schizophrenia patient fibroblast$246,000
R21 · FY2010 · MH · contact PI
Cell Models of RNA Neurotoxicity$213,098
R21 · FY2010 · NS · contact PI
Huntington's Disease Antisense Transcript$205,000
R21 · FY2010 · NS · contact PI
Genetics Core$162,320
P50 · FY2010 · NS · contact PI
A Novel Array For Detection of Unstable Tandem Repeats$221,400
R21 · FY2009 · MH · contact PI
Neurons from pluripotent stem cells derived from schizophrenia patient fibroblast$205,000
R21 · FY2009 · MH · contact PI
Cell Models of RNA Neurotoxicity$179,375
R21 · FY2009 · NS · contact PI
Genetics Core$152,947
P50 · FY2009 · NS · contact PI
A Mouse Model of RNA-induced Neurotoxcity$215,250
R21 · FY2008 · NS · contact PI
A Novel Array For Detection of Unstable Tandem Repeats$184,500
R21 · FY2008 · MH · contact PI
Genetics Core$152,930
P50 · FY2008 · NS · contact PI
A Mouse Model of RNA-induced Neurotoxcity$179,147
R21 · FY2007 · NS · contact PI
Genetics Core$173,240
P01 · FY2007 · NS · contact PI
Genetics Core$152,797
P01 · FY2006 · NS · contact PI
TRINUCLEOTIDE REPEATS AND NEUROLOGIC DISEASE$367,875
R01 · FY2004 · NS
TRINUCLEOTIDE REPEATS AND NEUROLOGIC DISEASE$367,875
R01 · FY2003 · NS
TRINUCLEOTIDE REPEATS AND NEUROLOGIC DISEASE$367,875
R01 · FY2002 · NS
PSYCHIATRIC SYMPTOMS IN NEURODEGENERATIVE DISORDERS$0
M01 · FY2002 · RR
TRINUCLEOTIDE REPEATS AND NEUROLOGIC DISEASE$368,063
R01 · FY2001 · NS
CORE--GENETICS$172,411
P01 · FY2001 · NS
PSYCHIATRIC SYMPTOMS IN NEURODEGENERATIVE DISORDERS$0
M01 · FY2001 · RR
TRINUCLEOTIDE REPEATS AND NEUROLOGIC DISEASE$369,000
R01 · FY2000 · NS
PSYCHIATRIC SYMPTOMS IN NEURODEGENERATIVE DISORDERS$0
M01 · FY2000 · RR